Shares of Novo Nordisk (NYSE: NVO) are falling this week, down 33% as of 3:27 p.m. ET on Friday. The drop comes as the S&P ...

Novo Nordisk stock plunges 30% after forecast cut, CEO shakeup, and rising competition hit investor confidence.

JOBS DAY: The latest jobs data today painted a picture of a much softer labor market all summer than was previously known, ...

For a while, Danish drugmaker Novo Nordisk A/S looked unstoppable. It was at the forefront of the weight-loss injection boom as people discovered that its Ozempic shot, originally developed to treat ...

The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Amid rising demand for popular medications, experts and industry groups are concerned regulators may not be able to keep pace ...

$2B for Mars: No, not the planet. That’s much more expensive. The family-owned U.S. candymaker says it plans to invest ...

Former Google CEO Eric Schmidt was among Anthropic’s first investors. He’d met Amodei through his then-girlfriend and now ...